Georgetown University LogoGeorgetown University Library LogoDigitalGeorgetown Home
    • Login
    View Item 
    •   DigitalGeorgetown Home
    • Georgetown University Institutional Repository
    • Georgetown University Medical Center
    • Lombardi Comprehensive Cancer Center
    • Program of Tumor Biology
    • Graduate Theses and Dissertations - Tumor Biology
    • View Item
    •   DigitalGeorgetown Home
    • Georgetown University Institutional Repository
    • Georgetown University Medical Center
    • Lombardi Comprehensive Cancer Center
    • Program of Tumor Biology
    • Graduate Theses and Dissertations - Tumor Biology
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Solute Carriers and Heat Shock Proteins Modulate Endocrine Therapy Resistance in Hormone Positive Breast Cancer

    Cover for Solute Carriers and Heat Shock Proteins Modulate Endocrine Therapy Resistance in Hormone Positive Breast Cancer
    View/Open
    View/Open: Sevigny_georgetown_0076D_14754.pdf (2.7MB) Bookview

    Creator
    Sevigny, Catherine
    Advisor
    Clarke, Robert
    ORCID
    0000-0001-5483-4738
    Abstract
    Resistance to endocrine therapies remains a major challenge for patients with estrogen receptor-positive (ER+) breast cancer. Adaptive reprogramming of cellular metabolism in response to treatment is one feature of this resistance. Solute carriers (SLCs) transport sugars, amino acids, and other nutrients, regulating their intracellular abundance. We found 109 SLC mRNAs to be differentially expressed between endocrine sensitive and resistant breast cancer cells. In univariate analyses, 55 of these SLC mRNAs were associated with poor outcome in ER+ breast cancer patients treated with an endocrine therapy. Data from tandem mass tag (TMT) and stable isotope labeling with amino acids in cell culture (SILAC) studies identified 20 SLC proteins that were upregulated and 35 that were down regulated in resistant compared with sensitive human breast cancer cells. TMT and SILAC also found an upregulation of heat shock proteins HSPB8 and BAG3 in endocrine resistant cells. We concluded that HSPB8 was upregulated by estrogen in sensitive cells; BAG3 decreased with estrogen treatment. Genetic targeting of HSPB8 reduced S phase, but we could not determine the mechanism by which HSP8 influenced autophagy. We focused our mechanistic studies on SLC7A5 (LAT1) which, in complex with SLC3A2 (CD98), is the primary transporter of large, neutral amino acids including leucine and tyrosine. LAT1 expression was estrogen-regulated in endocrine sensitive cells but this regulation was lost, and basal expression was increased, in resistant cells. Of two EREs we identified in the LAT1 gene, ChIP-qRT-PCR confirmed site Ch16: 87868314-87868373 where levels of H4 acetylation increased, while levels of H3K9 dimethylation decreased, with estrogen treatment. Pharmacologic inhibition or genetic depletion of LAT1 each suppressed global protein translation as measured by total puromycinylated protein levels and cell proliferation in endocrine resistant cells. Overexpression of the LAT1 cDNA increased protein synthesis in cells. This study uncovers a novel LAT1-mediated adaptive response that contributes to the development of endocrine resistance and illuminates a possible role for LAT1 activity, and that of other SLCs, as potential rate limiting steps in determining the proliferative capacity of ER+ breast cancer cells. Blocking LAT1 function may offer a new avenue for effective therapeutic intervention against endocrine resistant ER+ breast cancers.
    Description
    Ph.D.
    Permanent Link
    http://hdl.handle.net/10822/1060780
    Date Published
    2020
    Subject
    Breast Cancer; Endocrine Therapy Resistance; Heat Shock Protein; Solute Carrier; Cytology; Molecular biology; Cellular biology; Molecular biology;
    Type
    thesis
    Embargo Lift Date
    2022-01-29
    Publisher
    Georgetown University
    Extent
    137 leaves
    Collections
    • Graduate Theses and Dissertations - Tumor Biology
    Metadata
    Show full item record

    Related items

    Showing items related by title, author, creator and subject.

    • Cover for The Role of the ErbB2/PI 3-K/Akt1 Pathway in the Development of Hormone Resistance in Breast Cancer

      The Role of the ErbB2/PI 3-K/Akt1 Pathway in the Development of Hormone Resistance in Breast Cancer 

      Cesari, Whitney; Cesari, Whitney (2007-04-15)
      The presence of estrogen receptor α (ER-α) in breast tumors predicts the patient response to hormone therapy. The most common treatments are the antiestrogens 4- hydroxy tamoxifen (Tam) and fulvestrant (ICI 182,780). ...
    Related Items in Google Scholar

    Georgetown University Seal
    ©2009 - 2023 Georgetown University Library
    37th & O Streets NW
    Washington DC 20057-1174
    202.687.7385
    digitalscholarship@georgetown.edu
    Accessibility
     

     

    Browse

    All of DigitalGeorgetownCommunities & CollectionsCreatorsTitlesBy Creation DateThis CollectionCreatorsTitlesBy Creation Date

    My Account

    Login

    Statistics

    View Usage Statistics

    Georgetown University Seal
    ©2009 - 2023 Georgetown University Library
    37th & O Streets NW
    Washington DC 20057-1174
    202.687.7385
    digitalscholarship@georgetown.edu
    Accessibility